Onderneming 3SBio Inc. (ADR) Nasdaq
Aandelen
US88575Y1055
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
22/04 | 3Sbio Inc. Kondigt wijzigingen in het management aan | CI |
12/04 | 3SBio Inc. Keurt Recombinant Humane Trombopoëtine Injectie (TPIAO) goed voor Pediatrische ITP-indicatie | CI |
Vakgebied
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 7 977 | 100,0 % | 8 637 | 100,0 % | +8,27% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
97,2
%
| 7 734 | 97,0 % | 8 396 | 97,2 % | +8,56% |
Others
2,8
%
| 243 | 3,0 % | 240 | 2,8 % | -1,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 61 | 01-01-93 |
Xiang He
DFI | Director of Finance/CFO | - | 03-07-23 |
Dong Mei Su
BRD | Director/Board Member | 54 | 11-06-12 |
Bin Huang
BRD | Director/Board Member | 63 | 01-01-93 |
Dong Tao Luo
PRN | Corporate Officer/Principal | 48 | 01-03-16 |
Xin Ma
HRO | Human Resources Officer | 58 | - |
Siu Kuen Lai
SEC | Corporate Secretary | 48 | 27-11-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bin Huang
BRD | Director/Board Member | 63 | 01-01-93 |
Jing Lou
CEO | Chief Executive Officer | 61 | 01-01-93 |
Dong Mei Su
BRD | Director/Board Member | 54 | 11-06-12 |
Tian Ruo Pu
BRD | Director/Board Member | 55 | 01-06-15 |
Joo Yeow Ng
BRD | Director/Board Member | 59 | 21-01-22 |
Hoi Ti Yang
BRD | Director/Board Member | 54 | 29-06-21 |
Dan Zhang
BRD | Director/Board Member | 60 | 30-12-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 438 920 412 | 1 802 803 951 ( 73,92 %) | 40 357 688 ( 1,655 %) | 73,92 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
498 883 645 | 95.20% | 1 650 661 305 $ | |
SENSORION 1.35% | 4 055 150 | 1.35% | 3 026 521 $ |
Bedrijfsgegevens
3SBio, Inc.
Shenyang Economy & Tech Development No. 3 A1, Road 10
110027, Shenyang
+86 24 2538 6000
http://www.3sbio.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. |
Pharmaceuticals: Major
|
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,47% | 89,37 mld. | |
+2,76% | 40,65 mld. | |
-13,80% | 32,81 mld. | |
+52,41% | 25 mld. | |
-17,34% | 15,29 mld. | |
-42,45% | 11,61 mld. | |
-10,48% | 11,49 mld. | |
+6,14% | 8,98 mld. | |
-7,72% | 8,23 mld. |
- Beurs
- Aandelen
- Koers 1530
- Koers
- Onderneming 3SBio Inc. (ADR)